Papers
2
Total Citations
17
H-Index
2
About
Andrea Galli is a clinical researcher whose work sits at the intersection of interventional radiology and advanced radiation oncology, with a focused expertise in the treatment of liver malignancies. Her primary research area involves optimizing the technical workflow for stereotactic body radiation therapy (SBRT), specifically through the percutaneous, ultrasound-guided placement of fiducial markers. Galli’s major contributions include pioneering comparative analyses of different marker types and needle gauges to enhance the tracking accuracy of robotic radiosurgery systems like the CyberKnife. In her 2016 pilot study (9 citations), she established the therapeutic usability of two distinct gold markers, while her 2017 prospective trial (8 citations) systematically evaluated the feasibility and safety of three different marker-and-needle combinations. This work is critical for improving the precision of radiation delivery to liver tumors, directly impacting patient outcomes by reducing treatment margins and minimizing damage to healthy tissue. Galli’s research provides the foundational evidence needed for clinicians to select the most effective and safest fiducial placement technique, making her a key contributor to the advancement of non-invasive liver cancer treatments.
Research Focus
Key Achievements
Top Papers
- 1
- 2